All lobbying filings

ABBOTT LABORATORIES

Lobbying for ABBOTT LABORATORIES

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $900,000.00 expenses · posted Jan 20, 2026

Official filing document

Bills named in this filing 4

S 1000
A bill to establish an Ambassador-at-Large for Arctic Affairs.
HR 1835
MERIT Act
HR 2300
To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other pu…
S 2426
Equitable Community Access to Pharmacist Services Act

Lobbying activity 5

Medicare/Medicaid

S. 1000/H.R. 1835 Saving Access to Laboratory Services Act. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to Medicare coverage of continuous glucose monitors.

Trade (domestic/foreign)

Proposals related to U.S. global health programs and pandemic preparedness. Proposals to advance global virus surveillance.

Agriculture

H.R. 2300 To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. Proposals related to access to infant formula. Proposals regarding the implementation and modernization of the WIC Program.

Taxation/Internal Revenue Code

Proposals to reform domestic and international tax structures.

Health Issues

S. 2426 Equitable Community Access to Pharmacist Services Act. Proposals related to the advancement, testing and detection of Traumatic Brain Injury (TBI). Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.